 |
424 Diseases |  |
807 Trials |
|
807 Trials |  |
14372 News |  |
| «12...218219220221222223224225226227228...235236» |
- | thioguanine / Generic mfg., nelarabine / Generic mfg.
Trial completion: AALL00P2: Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P=N/A, N=100, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed
- 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Metastases: Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Prologue Research International
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Combination therapy: Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | bortezomib / Generic mfg., 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Combination therapy, Surgery, Metastases: Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery (clinicaltrials.gov) - Feb 19, 2014
P1, N=30, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Surgery, Metastases: Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P3, N=83, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | thioguanine / Generic mfg.
Trial completion: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P3, N=838, Completed, Sponsor: Children's Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | Trial completion, Metastases: SWOG-N9841: Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P3, N=560, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 19, 2014
P1, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Orzel (UFT + Leucovorin) / EMD Serono, Otsuka
Trial completion, Metastases: Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | uridine triacetate (PN 401) / Wellstat
Trial completion, Metastases: S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach (clinicaltrials.gov) - Feb 19, 2014
P2, N=65, Completed, Sponsor: Southwest Oncology Group
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: New York University School of Medicine
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Zokinvy (lonafarnib) / Eiger
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=25, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Radiation Therapy Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Surgery, Metastases: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=20, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion, Metastases: Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Grupo Oncologico Cooperativo del Sur
Active, not recruiting --> Completed No longer recruiting --> Completed
- | topotecan / Generic mfg., 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=30, Completed, Sponsor: New York University School of Medicine
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen
Biomarker, Trial completion: MISTRAL: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=400, Completed, Sponsor: Swiss Group for Clinical Cancer Research
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=54, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P3, N=116, Completed, Sponsor: M.D. Anderson Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Surgery: Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=50, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, IO biomarker: POG-9407: Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 19, 2014
P2, N=221, Completed, Sponsor: Children's Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=25, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., levamisole / Generic mfg.
Trial completion: SWOG 9415: S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed (clinicaltrials.gov) - Feb 19, 2014
P3, N=1135, Completed, Sponsor: Southwest Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=46, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | thioguanine / Generic mfg.
Trial completion: Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission (clinicaltrials.gov) - Feb 19, 2014
P3, N=1929, Completed, Sponsor: Eastern Cooperative Oncology Group
Active, not recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Mustargen (mechlorethamine) / Recordati, Matulane (procarbazine hydrochloride) / Leadiant Biosci
Trial completion: Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=4, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion: A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Erbitux (cetuximab) / Eli Lilly
Trial initiation date: Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=60, Recruiting, Sponsor: Cliniques universitaires Saint-Luc- Universit
Active, not recruiting --> Completed Initiation date: May 2013 --> Jan 2014
- Cyramza (ramucirumab) / Eli Lilly
New P1 trial, Metastases: A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=9, Not yet recruiting, Sponsor: Eli Lilly and Company
- Erbitux (cetuximab) / Eli Lilly
Enrollment open: Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors (clinicaltrials.gov) - Feb 19, 2014
P2, N=60, Recruiting, Sponsor: Cliniques universitaires Saint-Luc- Universit
Initiation date: May 2013 --> Jan 2014 Not yet recruiting --> Recruiting
- | Erbitux (cetuximab) / Eli Lilly
New P2 trial, Metastases: FOCULM: FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 12, 2014
P2, N=106, Recruiting, Sponsor: Sun Yat-sen University
- ||| Epratucyn (epratuzumab) / Gilead
Enrollment closed: Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) (clinicaltrials.gov) - Feb 12, 2014
P1/2, N=134, Active, not recruiting, Sponsor: Children's Oncology Group
Not yet recruiting --> Recruiting Completed --> Active, not recruiting
- ||| Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment change, IO biomarker: POG-9407: Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 11, 2014
P2, N=221, Completed, Sponsor: Children's Oncology Group
Completed --> Active, not recruiting N=104 --> 221
- |||| Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: OLIVIA: A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. (clinicaltrials.gov) - Feb 10, 2014
P2, N=81, Completed, Sponsor: Hoffmann-La Roche
N=104 --> 221 Active, not recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Biomarker, Enrollment closed: Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer (clinicaltrials.gov) - Feb 6, 2014
P3, N=2389, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Completed --> Active, not recruiting
- Rituxan (rituximab) / Roche
Trial completion: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma (clinicaltrials.gov) - Feb 5, 2014
P2, N=34, Completed, Sponsor: AIDS Malignancy Clinical Trials Consortium
Completed --> Active, not recruiting Active, not recruiting --> Completed
- Reolysin (pelareorep) / Oncolytics, Andrus Reo
Enrollment open, Combination therapy, Metastases: Study of REOLYSIN (clinicaltrials.gov) - Feb 4, 2014
P1, N=20, Recruiting, Sponsor: Oncolytics Biotech
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- ||| napabucasin (BBI608) / Sumitomo Pharma
Enrollment open, Combination therapy, Metastases: A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer (clinicaltrials.gov) - Feb 2, 2014
P1, N=144, Recruiting, Sponsor: Boston Biomedical, Inc
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||||| Vectibix (panitumumab) / Amgen
Trial completion: PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy (clinicaltrials.gov) - Feb 2, 2014
P3, N=1183, Completed, Sponsor: Amgen
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Avastin (bevacizumab) / Roche
Enrollment change, Combination therapy, Metastases: Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Jan 28, 2014
P1, N=3, Completed, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed N=18 --> 3
- oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg., everolimus / Generic mfg.
Enrollment closed, Metastases: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (clinicaltrials.gov) - Jan 28, 2014
P1/2, N=44, Active, not recruiting, Sponsor: City of Hope Medical Center
N=18 --> 3 Recruiting --> Active, not recruiting
- Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Jan 28, 2014
P1, N=3, Completed, Sponsor: City of Hope Medical Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- oxaliplatin / Generic mfg., irinotecan / Generic mfg.
New P2 trial, Surgery: Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer (clinicaltrials.gov) - Jan 26, 2014
P2, N=46, Recruiting, Sponsor: Yale University
- | Avastin (bevacizumab) / Roche
Enrollment open, Metastases: AXEPT: A Phase III Study of 2nd-line XELIRI (clinicaltrials.gov) - Jan 26, 2014
P3, N=600, Recruiting, Sponsor: Epidemiological and Clinical Research Information Network
Active, not recruiting --> Completed Not yet recruiting --> Recruiting